Insulet, headquartered in Acton, Massachusetts, develops and markets insulin infusion systems, including the Omnipod 5 Automated Insulin Delivery System, for insulin-dependent diabetes. The company employs 3,000 staff and went public in 2007.
PODD has been in the news recently: Insulet Corporation (PODD) reported first-quarter adjusted earnings of $1.02 per share, exceeding the consensus estimate of 80 cents, which led to a more than 19% increase in its stock price. The company also generated $569 million in revenue, surpassing analyst expectations.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.